Biocompatibility Innovation (BCI) is a biotech company founded in 2014 by scientific researchers with over 15 years of experience in Cardiovascular Tissue Engineering and Regenerative Medicine. The company's focus is on improving the durability and biocompatibility of implantable medical devices, including biologic and polymeric types, for various surgical applications. BCI acts as a service provider for both private and public institutions, operating in the Biotechnology and Medical Devices industries. Based in Italy, BCI's slogan "Go beyond the barriers" reflects its commitment to pushing the boundaries of biocompatibility in the medical field. As of now, there is no record of last investment or last investment investors, indicating potential opportunities for venture capital investment.
There is no investment information
No recent news or press coverage available for Biocompatibility Innovation.